Trial Profile
Lanreotide Autogel for the treatment of patients with Idiopathic Pulmonary Fibrosis (IPF)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 May 2014
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 29 May 2014 New trial record